Cargando…

Association of NCOA3 (AIB1) polymorphisms with breast cancer risk

Detalles Bibliográficos
Autores principales:	Burwinkel, B, Wirtenberger, M, Frank, B, Klaes, R, Schmutzler, RK, Grzybowska, E, Försti, A, Bermejo, JL, Bugert, P, Wappenschmidt, B, Butkiewicz, D, Pamula, J, Pekala, W, Zientek, H, Mielzynska, D, Siwinska, E, Bartram, CR, Hemminki, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233528/ http://dx.doi.org/10.1186/bcr1107

Ejemplares similares

The rare ERBB2 variant Ile654Val is associated with an increased familial breast cancer risk
por: Frank, B, et al.
Publicado: (2005)

TP53-binding protein variants and breast cancer risk: a case-control study
por: Frank, Bernd, et al.
Publicado: (2005)

High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk
por: Wagner, Kerstin, et al.
Publicado: (2007)

BRIP1 (BACH1) variants and familial breast cancer risk: a case-control study
por: Frank, Bernd, et al.
Publicado: (2007)

Allelotyping of pooled DNA with 250 K SNP microarrays
por: Wilkening, Stefan, et al.
Publicado: (2007)

AIB1/SRC-3/NCOA3 function in estrogen receptor alpha positive breast cancer
por: Kiliti, Amber J., et al.
Publicado: (2023)

Transcription factor 7-like 2 (TCF7L2) variant is associated with familial breast cancer risk: a case-control study
por: Burwinkel, Barbara, et al.
Publicado: (2006)

Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland
por: Pamuła, Jolanta, et al.
Publicado: (2006)

Identification of novel sequence alterations and the functional analysis of the BRCA1 promoter/5'-UTR in families from Upper Silesia, Poland
por: Pamuła, J, et al.
Publicado: (2005)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

The AIBE and the new phase of the RBHH
por: Maiolino, Ângelo
Publicado: (2011)

Polymorphisms in the CRK gene and their association with breast cancer risk
por: Wagner, K, et al.
Publicado: (2005)

Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
por: Hartmaier, Ryan J, et al.
Publicado: (2009)

Mechanism of 3‐Methylglutaconyl CoA Decarboxylase AibA/AibB: Pericyclic Reaction versus Direct Decarboxylation
por: Sheng, Xiang, et al.
Publicado: (2020)

Gene expression signature of hereditary breast cancer
por: Dudaladava, V, et al.
Publicado: (2005)

Crystal structures of Z–Gly–Aib–O(−)·0.5Ca(2+)·H(2)O and Z–Gly–Aib–OH
por: Gessmann, Renate, et al.
Publicado: (2018)

The ‘Common Disease-Common Variant’ Hypothesis and Familial Risks
por: Hemminki, Kari, et al.
Publicado: (2008)

Single nucleotide polymorphisms (SNPs) are inherited from parents and they measure heritable events
por: Hemminki, Kari, et al.
Publicado: (2005)

DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA
por: Tang, Qiuqiong, et al.
Publicado: (2016)

CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions
por: Giamas, Georgios, et al.
Publicado: (2009)

Strong evidence that the common variant S384F in BRCA2 has no pathogenic relevance in hereditary breast cancer
por: Wappenschmidt, B, et al.
Publicado: (2005)

Retraction of ‘CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions’
Publicado: (2021)

Expression of AIB1 protein as a prognostic factor in breast cancer
por: Lee, Kyungji, et al.
Publicado: (2011)

Phosphorylation of AIB1 at Mitosis Is Regulated by CDK1/CYCLIN B
por: Ferrero, Macarena, et al.
Publicado: (2011)

Polymorphic repeat in AIB1 does not alter breast cancer risk
por: Haiman, Christopher A, et al.
Publicado: (2000)

The 2020 AIB curriculum survey: The state of internationalizing students, faculty, and programs
por: Kwok, Chuck C. Y., et al.
Publicado: (2022)

Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer
por: Weiner, M., et al.
Publicado: (2013)

The Role of NCOA4-Mediated Ferritinophagy in Health and Disease
por: Santana-Codina, Naiara, et al.
Publicado: (2018)

Nuclear Receptor Coactivators (NCOAs) and Corepressors (NCORs) in the Brain
por: Sun, Zheng, et al.
Publicado: (2020)

Crystal structure of the TLDc domain of human NCOA7-AS
por: Arnaud-Arnould, Mary, et al.
Publicado: (2021)

NCOA4: More than a receptor for ferritinophagy
por: Wang, Zheng, et al.
Publicado: (2022)

Acetylation Enhances the Promoting Role of AIB1 in Breast Cancer Cell Proliferation
por: You, Dingyun, et al.
Publicado: (2016)

The influence of solvent on conformational properties of peptides with Aib residue—a DFT study
por: Wałęsa, Roksana, et al.
Publicado: (2017)

Editorial Expression of Concern on article ‘CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions’
Publicado: (2021)

Essential roles for the nuclear receptor coactivator Ncoa3 in pluripotency
por: Percharde, Michelle, et al.
Publicado: (2013)

Association of NCOA3 polymorphisms with Dyslipidemia in the Chinese Han population
por: Yu, Mingxi, et al.
Publicado: (2015)

NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration
por: Quiles del Rey, Maria, et al.
Publicado: (2019)

Expression and clinical significance of NCOA5 in epithelial ovarian cancer
por: Song, Xiaoping, et al.
Publicado: (2023)

Gene Expression Profiling in Hereditary, BRCA1-linked Breast Cancer: Preliminary Report
por: Dudaladava, Volha, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_a70l8f6kve230033v3d7qn7hb0